Literature DB >> 21168297

Bioanalytical method development and validation of natamycin in rabbit tears and its application to ocular pharmacokinetic studies.

R S Bhatta1, H Chandasana, C Rathi, D Kumar, Y S Chhonker, G K Jain.   

Abstract

A new selective and sensitive high-performance liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) method was developed for the quantification of natamycin in rabbit tears using amphotericin B as internal standard (IS). Chromatographic separation was achieved on a Luna Cyano column (100 mm × 2 mm, 3 μm) using ammonium acetate buffer (pH 4; 3.5mM): methanol (10:90, v/v) as the mobile phase. The run time was 5 min. Detection was performed by negative ion electrospray ionization in multiple reaction monitoring (MRM) mode. The calibration curve was linear over the concentration range from 25 to 800 ng/ml, and lower limit of detection of 12.5 ng/ml. The accuracy and precision of the method were within the acceptable limit of ± 20% at the lower limit of quantitation and ± 15% at other concentrations. Natamycin was stable during the battery of stability studies viz., bench-top, auto-sampler, freeze/thaw cycles and 30 days storage in a freezer at -70 ± 10 °C. The method was successfully applied to the ocular pharmacokinetic studies of natamycin eye drops in New Zealand rabbit tears.
Copyright © 2010. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21168297     DOI: 10.1016/j.jpba.2010.11.028

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

1.  LC-MS/MS assay for the determination of natamycin in rabbit and human plasma: Application to a pharmacokinetics and protein binding study.

Authors:  Yashpal Singh Chhonker; Devendra Kumar; Pankaj Shrivastava; Deepak Kumar; Rajbir Singh; Hardik Chandasana; Rabi Sankar Bhatta
Journal:  J Pharm Anal       Date:  2012-12-12

2.  Development and validation of a bioanalytical method for quantification of 2,6-bis-(4-hydroxy-3-methoxybenzylidene)-cyclohexanone (BHMC) in rat plasma.

Authors:  Yu Zhao Lee; Lee Ming-Tatt; Nordin Hj Lajis; Mohd Roslan Sulaiman; Daud Ahmad Israf; Chau Ling Tham
Journal:  Molecules       Date:  2012-12-07       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.